Table of Content

1 Indoleamine 2,3 Dioxygenase 1 Market Overview
1.1 Indoleamine 2,3 Dioxygenase 1 Product Overview
1.2 Indoleamine 2,3 Dioxygenase 1 Market Segment by Type
1.2.1 BMS-986205
1.2.2 Dcellvax
1.2.3 Epacadostat
1.2.4 F-001287
1.2.5 Galanal
1.2.6 Others
1.3 Global Indoleamine 2,3 Dioxygenase 1 Market Size by Type
1.3.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size Overview by Type (2018-2034)
1.3.2 Global Indoleamine 2,3 Dioxygenase 1 Historic Market Size Review by Type (2018-2024)
1.3.3 Global Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2018-2024)
1.4.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2018-2024)
2 Global Indoleamine 2,3 Dioxygenase 1 Market Competition by Company
2.1 Global Top Players by Indoleamine 2,3 Dioxygenase 1 Sales (2018-2024)
2.2 Global Top Players by Indoleamine 2,3 Dioxygenase 1 Revenue (2018-2024)
2.3 Global Top Players by Indoleamine 2,3 Dioxygenase 1 Price (2018-2024)
2.4 Global Top Manufacturers Indoleamine 2,3 Dioxygenase 1 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Indoleamine 2,3 Dioxygenase 1 Market Competitive Situation and Trends
2.5.1 Indoleamine 2,3 Dioxygenase 1 Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Indoleamine 2,3 Dioxygenase 1 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Indoleamine 2,3 Dioxygenase 1 as of 2022)
2.7 Date of Key Manufacturers Enter into Indoleamine 2,3 Dioxygenase 1 Market
2.8 Key Manufacturers Indoleamine 2,3 Dioxygenase 1 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Indoleamine 2,3 Dioxygenase 1 Status and Outlook by Region
3.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Indoleamine 2,3 Dioxygenase 1 Historic Market Size by Region
3.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2018-2024)
3.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales in Value by Region (2018-2024)
3.2.3 Global Indoleamine 2,3 Dioxygenase 1 Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Region
3.3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2024-2034)
3.3.2 Global Indoleamine 2,3 Dioxygenase 1 Sales in Value by Region (2024-2034)
3.3.3 Global Indoleamine 2,3 Dioxygenase 1 Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Indoleamine 2,3 Dioxygenase 1 by Application
4.1 Indoleamine 2,3 Dioxygenase 1 Market Segment by Application
4.1.1 Aolpecia
4.1.2 Cervical Cancer
4.1.3 Gastric Cancer
4.1.4 Glioma
4.1.5 Others
4.2 Global Indoleamine 2,3 Dioxygenase 1 Market Size by Application
4.2.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size Overview by Application (2018-2034)
4.2.2 Global Indoleamine 2,3 Dioxygenase 1 Historic Market Size Review by Application (2018-2024)
4.2.3 Global Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2018-2024)
4.3.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2018-2024)
5 North America Indoleamine 2,3 Dioxygenase 1 by Country
5.1 North America Indoleamine 2,3 Dioxygenase 1 Historic Market Size by Country
5.1.1 North America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2018-2024)
5.1.3 North America Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2018-2024)
5.2 North America Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Country
5.2.1 North America Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2024-2034)
5.2.2 North America Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2024-2034)
6 Europe Indoleamine 2,3 Dioxygenase 1 by Country
6.1 Europe Indoleamine 2,3 Dioxygenase 1 Historic Market Size by Country
6.1.1 Europe Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2018-2024)
6.1.3 Europe Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2018-2024)
6.2 Europe Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Country
6.2.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2024-2034)
6.2.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2024-2034)
7 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 by Region
7.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Historic Market Size by Region
7.1.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Region
7.2.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales in Value by Region (2024-2034)
8 Latin America Indoleamine 2,3 Dioxygenase 1 by Country
8.1 Latin America Indoleamine 2,3 Dioxygenase 1 Historic Market Size by Country
8.1.1 Latin America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2018-2024)
8.1.3 Latin America Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2018-2024)
8.2 Latin America Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Country
8.2.1 Latin America Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2024-2034)
8.2.2 Latin America Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2024-2034)
9 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 by Country
9.1 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Historic Market Size by Country
9.1.1 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Country
9.2.1 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 BirchBioMed Inc
10.1.1 BirchBioMed Inc Company Information
10.1.2 BirchBioMed Inc Introduction and Business Overview
10.1.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.1.4 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Products Offered
10.1.5 BirchBioMed Inc Recent Development
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Company Information
10.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Products Offered
10.2.5 Bristol-Myers Squibb Company Recent Development
10.3 Ensemble Therapeutics Corp
10.3.1 Ensemble Therapeutics Corp Company Information
10.3.2 Ensemble Therapeutics Corp Introduction and Business Overview
10.3.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Products Offered
10.3.5 Ensemble Therapeutics Corp Recent Development
10.4 F. Hoffmann-La Roche Ltd
10.4.1 F. Hoffmann-La Roche Ltd Company Information
10.4.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.4.4 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Products Offered
10.4.5 F. Hoffmann-La Roche Ltd Recent Development
10.5 Genentech Inc
10.5.1 Genentech Inc Company Information
10.5.2 Genentech Inc Introduction and Business Overview
10.5.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Products Offered
10.5.5 Genentech Inc Recent Development
10.6 Globavir Biosciences Inc
10.6.1 Globavir Biosciences Inc Company Information
10.6.2 Globavir Biosciences Inc Introduction and Business Overview
10.6.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Products Offered
10.6.5 Globavir Biosciences Inc Recent Development
10.7 Incyte Corp
10.7.1 Incyte Corp Company Information
10.7.2 Incyte Corp Introduction and Business Overview
10.7.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Products Offered
10.7.5 Incyte Corp Recent Development
10.8 IO Biotech ApS
10.8.1 IO Biotech ApS Company Information
10.8.2 IO Biotech ApS Introduction and Business Overview
10.8.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.8.4 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Products Offered
10.8.5 IO Biotech ApS Recent Development
10.9 Kyowa Hakko Kirin
10.9.1 Kyowa Hakko Kirin Company Information
10.9.2 Kyowa Hakko Kirin Introduction and Business Overview
10.9.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Products Offered
10.9.5 Kyowa Hakko Kirin Recent Development
10.10 Netherlands Translational Research Center BV
10.10.1 Netherlands Translational Research Center BV Company Information
10.10.2 Netherlands Translational Research Center BV Introduction and Business Overview
10.10.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Products Offered
10.10.5 Netherlands Translational Research Center BV Recent Development
10.11 NewLink Genetics Corp
10.11.1 NewLink Genetics Corp Company Information
10.11.2 NewLink Genetics Corp Introduction and Business Overview
10.11.3 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.11.4 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Products Offered
10.11.5 NewLink Genetics Corp Recent Development
10.12 Pfizer Inc
10.12.1 Pfizer Inc Company Information
10.12.2 Pfizer Inc Introduction and Business Overview
10.12.3 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Products Offered
10.12.5 Pfizer Inc Recent Development
10.13 Redx Pharma Plc
10.13.1 Redx Pharma Plc Company Information
10.13.2 Redx Pharma Plc Introduction and Business Overview
10.13.3 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Products Offered
10.13.5 Redx Pharma Plc Recent Development
10.14 Regen BioPharma Inc
10.14.1 Regen BioPharma Inc Company Information
10.14.2 Regen BioPharma Inc Introduction and Business Overview
10.14.3 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Products Offered
10.14.5 Regen BioPharma Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Indoleamine 2,3 Dioxygenase 1 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Indoleamine 2,3 Dioxygenase 1 Industrial Chain Analysis
11.4 Indoleamine 2,3 Dioxygenase 1 Market Dynamics
11.4.1 Indoleamine 2,3 Dioxygenase 1 Industry Trends
11.4.2 Indoleamine 2,3 Dioxygenase 1 Market Drivers
11.4.3 Indoleamine 2,3 Dioxygenase 1 Market Challenges
11.4.4 Indoleamine 2,3 Dioxygenase 1 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Indoleamine 2,3 Dioxygenase 1 Distributors
12.3 Indoleamine 2,3 Dioxygenase 1 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of BMS-986205
Table 2. Major Company of Dcellvax
Table 3. Major Company of Epacadostat
Table 4. Major Company of F-001287
Table 5. Major Company of Galanal
Table 6. Major Company of Others
Table 7. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (US& Million)
Table 11. Global Indoleamine 2,3 Dioxygenase 1 Market Share in Value by Type (2018-2024)
Table 12. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type (2024-2034)
Table 17. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Indoleamine 2,3 Dioxygenase 1 Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Indoleamine 2,3 Dioxygenase 1 Sales Share by Company (2018-2024)
Table 30. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Indoleamine 2,3 Dioxygenase 1 Revenue Share by Company (2018-2024)
Table 32. Global Market Indoleamine 2,3 Dioxygenase 1 Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Indoleamine 2,3 Dioxygenase 1 Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Indoleamine 2,3 Dioxygenase 1 as of 2022)
Table 36. Date of Key Manufacturers Enter into Indoleamine 2,3 Dioxygenase 1 Market
Table 37. Key Manufacturers Indoleamine 2,3 Dioxygenase 1 Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Indoleamine 2,3 Dioxygenase 1 Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Region (2018-2024)
Table 44. Global Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Region (2024-2034)
Table 49. Global Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application (2018-2024)
Table 55. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application (2024-2034)
Table 60. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) (K Pcs)
Table 62. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2018-2024)
Table 75. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Country (2024-2034)
Table 111. BirchBioMed Inc Company Information
Table 112. BirchBioMed Inc Introduction and Business Overview
Table 113. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product
Table 115. BirchBioMed Inc Recent Development
Table 116. Bristol-Myers Squibb Company Company Information
Table 117. Bristol-Myers Squibb Company Introduction and Business Overview
Table 118. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product
Table 120. Bristol-Myers Squibb Company Recent Development
Table 121. Ensemble Therapeutics Corp Company Information
Table 122. Ensemble Therapeutics Corp Introduction and Business Overview
Table 123. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product
Table 125. Ensemble Therapeutics Corp Recent Development
Table 126. F. Hoffmann-La Roche Ltd Company Information
Table 127. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 128. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product
Table 130. F. Hoffmann-La Roche Ltd Recent Development
Table 131. Genentech Inc Company Information
Table 132. Genentech Inc Introduction and Business Overview
Table 133. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product
Table 135. Genentech Inc Recent Development
Table 136. Globavir Biosciences Inc Company Information
Table 137. Globavir Biosciences Inc Introduction and Business Overview
Table 138. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product
Table 140. Globavir Biosciences Inc Recent Development
Table 141. Incyte Corp Company Information
Table 142. Incyte Corp Introduction and Business Overview
Table 143. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product
Table 145. Incyte Corp Recent Development
Table 146. IO Biotech ApS Company Information
Table 147. IO Biotech ApS Introduction and Business Overview
Table 148. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product
Table 150. IO Biotech ApS Recent Development
Table 151. Kyowa Hakko Kirin Company Information
Table 152. Kyowa Hakko Kirin Introduction and Business Overview
Table 153. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product
Table 155. Kyowa Hakko Kirin Recent Development
Table 156. Netherlands Translational Research Center BV Company Information
Table 157. Netherlands Translational Research Center BV Introduction and Business Overview
Table 158. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 159. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product
Table 160. Netherlands Translational Research Center BV Recent Development
Table 161. NewLink Genetics Corp Company Information
Table 162. NewLink Genetics Corp Introduction and Business Overview
Table 163. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 164. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product
Table 165. NewLink Genetics Corp Recent Development
Table 166. Pfizer Inc Company Information
Table 167. Pfizer Inc Introduction and Business Overview
Table 168. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 169. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product
Table 170. Pfizer Inc Recent Development
Table 171. Redx Pharma Plc Company Information
Table 172. Redx Pharma Plc Introduction and Business Overview
Table 173. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 174. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product
Table 175. Redx Pharma Plc Recent Development
Table 176. Regen BioPharma Inc Company Information
Table 177. Regen BioPharma Inc Introduction and Business Overview
Table 178. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 179. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product
Table 180. Regen BioPharma Inc Recent Development
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Indoleamine 2,3 Dioxygenase 1 Market Trends
Table 184. Indoleamine 2,3 Dioxygenase 1 Market Drivers
Table 185. Indoleamine 2,3 Dioxygenase 1 Market Challenges
Table 186. Indoleamine 2,3 Dioxygenase 1 Market Restraints
Table 187. Indoleamine 2,3 Dioxygenase 1 Distributors List
Table 188. Indoleamine 2,3 Dioxygenase 1 Downstream Customers
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Indoleamine 2,3 Dioxygenase 1 Product Picture
Figure 2. Global Indoleamine 2,3 Dioxygenase 1 Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Indoleamine 2,3 Dioxygenase 1 Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Indoleamine 2,3 Dioxygenase 1 Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of BMS-986205
Figure 6. Global BMS-986205 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Dcellvax
Figure 8. Global Dcellvax Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Epacadostat
Figure 10. Global Epacadostat Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of F-001287
Figure 12. Global F-001287 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Galanal
Figure 14. Global Galanal Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type in 2022 & 2034
Figure 19. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2022
Figure 20. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2022
Figure 21. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2022
Figure 22. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2022
Figure 25. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Indoleamine 2,3 Dioxygenase 1 Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Indoleamine 2,3 Dioxygenase 1 Revenue in 2022
Figure 31. Indoleamine 2,3 Dioxygenase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Aolpecia
Figure 33. Global Aolpecia Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Cervical Cancer
Figure 35. Global Cervical Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Gastric Cancer
Figure 37. Global Gastric Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Glioma
Figure 39. Global Glioma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application in 2022 & 2034
Figure 44. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2022
Figure 45. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2022
Figure 46. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2022
Figure 47. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2022
Figure 50. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Indoleamine 2,3 Dioxygenase 1 Manufacturing Cost Structure
Figure 55. Indoleamine 2,3 Dioxygenase 1 Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed